Jim Simons
ONCE

Jim Simons’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Jim Simons’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-389,700
Closed -$39.9M – 3852
2019
Q2 		$39.9M Buy
+389,700
New +$42.1M 0.04% 583
2019
Q1 		– Sell
-322,962
Closed -$12.6M – 3812
2018
Q4 		$12.6M Buy
322,962
+131,762
+69% +$5.71M 0.01% 1170
2018
Q3 		$10.4M Buy
191,200
+135,200
+241% +$9.25M 0.01% 1331
2018
Q2 		$4.63M Buy
+56,000
New +$4.32M 0.01% 1828

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Jim Simons's ONCE Position: Q3 2019 in Review

Jim Simons sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 389,700 shares — an estimated $39.9M sold.

Jim Simons first reported a position in ONCE in Q2 2018 and held it in 4 quarters. The position peaked at $39.9M in Q2 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Jim Simons reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Jim Simons sold 389,700 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $39.9M.
  • Jim Simons first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • Jim Simons's Spark Therapeutics, Inc. Common Stock position peaked at $39.9M in Q2 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.